| Literature DB >> 24069051 |
Laila Y Al-Ayadhi1, Nadra Elyass Elamin.
Abstract
Extensive studies have demonstrated that oxidative stress plays a vital role in the pathology of several neurological diseases, including autism spectrum disorder (ASD); those studies proposed that GSH and antioxidant enzymes have a pathophysiological role in autism. Furthermore, camel milk has emerged to have potential therapeutic effects in autism. The aim of the current study was to evaluate the effect of camel milk consumption on oxidative stress biomarkers in autistic children, by measuring the plasma levels of glutathione, superoxide dismutase, and myeloperoxidase before and 2 weeks after camel milk consumption, using the ELISA technique. All measured parameters exhibited significant increase after camel milk consumption (P < 0.5). These findings suggest that camel milk could play an important role in decreasing oxidative stress by alteration of antioxidant enzymes and nonenzymatic antioxidant molecules levels, as well as the improvement of autistic behaviour as demonstrated by the improved Childhood Autism Rating Scale (CARS).Entities:
Year: 2013 PMID: 24069051 PMCID: PMC3773435 DOI: 10.1155/2013/602834
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Glutathione, superoxide dismutase, and myeloperoxidase in plasma of autistic children together with CARS before and 2 weeks after camel milk consumption.
| Raw milk ( | Boiled milk ( | Placebo ( | ||||
|---|---|---|---|---|---|---|
| Mean ± SEM |
| Mean ± SEM |
| Mean ± SEM |
| |
| Glutathione | ||||||
| Before | 0.37 ± 0.03 | 0.05 | 0.34 ± 0.03 | 0.02 | 0.36 ± 0.02 | 0.5 |
| After | 0.41 ± 0.01 | 0.45 ± 0.02 | 0.35 ± 0.04 | |||
| SOD | ||||||
| Before | 0.54 ± 0.03 | 0.2 | 0.49 ± 0.02 | 0.007 | 0.52 ± 0.03 | 0.5 |
| After | 0.59 ± 0.02 | 0.57 ± 0.02 | 0.54 ± 0.03 | |||
| MPO | ||||||
| Before | 2.65 ± 0.17 | 0.05 | 2.44 ± 0.13 | 0.02 | 2.11 ± 0.37 | 0.2 |
| After | 3.22 ± 0.24 | 3.08 ± 0.19 | 2.62 ± 0.16 | |||
| CARS | ||||||
| Before | 37.63 ± 6.31 | 0.004 | 36.82 ± 3.27 | 0.001 | 34.18 ± 3.25 | 0.772 |
| After | 34.54 ± 5.19 | 33.80 ± 4.91 | 34.41 ± 3.25 | |||
Figure 1Levels of (a) GSH, (b) SOD, (c) MPO, and (d) CARS in autistic patients before and after treating with the camel milk. The mean value for each group is designated by a line.
ROC curve of GSH, SOD, MPO, and CARS of autistic patients before and after treatment with camel milk.
| Parameters | Raw camel milk | Boiled Camel milk | Placebo | |
|---|---|---|---|---|
| GSH | Area under the curve | 0.677 | 0.723 | 0.504 |
| Best cut-off value | 0.357 | 0.356 | 0.326 | |
| Sensitivity% | 83.3 | 88.0 | 45.5 | |
| Specificity% | 62.5 | 72.0 | 72.7 | |
|
| ||||
| SOD | Area under the curve | 0.642 | 0.706 | 0.591 |
| Best cut-off value | 0.453 | 0.562 | 0.585 | |
| Sensitivity% | 95.8% | 56.0% | 54.5 | |
| Specificity% | 41.7% | 88.0% | 72.7 | |
|
| ||||
| MPO | Area under the curve | 0.584 | 0.703 | 0.702 |
| Best cut-off value | 3.17 | 2.385 | 2.180 | |
| Sensitivity% | 45.8% | 76.0% | 90.9% | |
| Specificity% | 79.2% | 64.0% | 54.4% | |
|
| ||||
| CARS | Area under the curve | 0.729 | 0.682 | 0.512 |
| Best cut-off value | 35.5 | 33.75 | 37.25 | |
| Sensitivity% | 70.8 | 44.0 | 81.8 | |
| Specificity% | 70.8 | 96.0 | 36.4 | |
Figure 2((a)–(d)): ROC curves showing specificity, sensitivity, and area under the curves for (a) GSH, (b) SOD, (c) MPO, and (d) CARS.